Directors and Advisers


Julian Baines, Non-Executive Chairman

Group CEO, EKF Diagnostics Holdings plc; former CEO & Managing Director BBI Holdings plc

James McCullough, MBA, CEO

Partner, Renwick Capital; former CEO, Exosome Diagnostics; co-Founder PAIGE.AI

Richard Evans, MBA

CFO EKF Diagnostics Holdings plc; Finance Manager, Global Account Director at Hitachi Data Systems

Christopher Mills

CEO and Partner, Harwood Capital LLP; CEO and Investment Manager North Atlantic Smaller Companies Investment Trust

Fergus Fleming, CTO

Managing Director, FF Consulting; former senior project manager, EKF Diagnostics Holdings plc

Barbara Murphy, MD

Murray M. Rosenberg Professor of Medicine; Chair of the Department of Medicine for the Mount Sinai Health System; Dean for Clinical Integration and Population Health

Erik Lium, PhD

Executive Vice President, Innovation Partners, Mount Sinai Health System

Senior Managers

O. James Sterling, CFO

Partner, Renwick Capital; former Managing Director, Brock Capital Group and Aleutian Capital Partners; management consultant, Booz Allen

Sally Bowden, COO

President of Bowden Consulting Group, Inc., focussing on quality and regulatory field in medical devices, companion diagnostics, education and health care systems

Michael J. Donovan, PhD, MD

Graduate from Rutgers University with a B.S. in zoology, a M.S. in endocrinology and a PhD in cell and developmental biology with post-doctoral studies at Harvard Medical School. He received his M.D. from the University of Medicine and Dentistry of New Jersey

CKD Advisory Board

Chirag R Parikh, MD, PhD, Chair

Director, Division of Nephrology, Ronald Peterson Professor of Medicine, Johns Hopkins School of Medicine

Steve Coca, DO, co-Founder

Associate Professor, Medicine, Nephrology; Associate Chair for Clinical and Translational Research for the Department of Internal Medicine, Mount Sinai Health System

Girish Nadkarni, MD, co-Founder

Assistant Professor of Medicine, Division of Nephrology; Clinical Director of the Charles Bronfman Institute for Personalized Medicine Mount Sinai Health System

Judy Cho, MD

Director and Associate Dean for Precision Medicine, Ward-Coleman Professor of Translational Genetics and Medicine Mount Sinai Health System

John Cijiang He, MD

Professor of Medicine and Pharmacological Sciences, Irene; Dr. Arthur Fishberg endowed Chair of Nephrology, Mount Sinai Health System

Joseph Boystak

Managing partner at Health2047 Capital Partners and managing director of Corporate Development at Health2047 Inc. Chair and co-chief executive of NanoPacific Holdings, Inc., Founder of Brightwaters Capital, LLC.

John Quackenbush, PhD

Professor of Computational Biology and Bioinformatics, Harvard T.H. Chan School of Public Health; Professor of Cancer Biology, Dana-Farber Cancer Institute

Joseph V. Bonventre, MD, PhD

Samuel A. Levine Professor of Medicine, Harvard Medical School. Chief of the Division of Renal Medicine and Chief of the Biomedical Engineering Division, Brigham and Women’s Hospital (BWH)

Barry Freedman, MD, FACP

John H. Felts, III Professor of Medicine and Chief of the Section on Nephrology and Executive Director of the Kidney and Dialysis Service, Wake Forest Baptist Health

Susan Quaggin, MD

Director, Feinberg Cardiovascular and Renal Research Institute, Chief of Nephrology and Hypertension, Department of Medicine

Kidney Transplant Advisory Board

Barbara Murphy, MD. Chair

Murray M. Rosenberg Professor of Medicine, Chair of the Department of Medicine and Dean for Clinical Integration & Population Health, Chair of the Kidney Transplant Advisory Board, Mount Sinai Health Systems

Richard Formica, MD

Professor of Medicine (Nephrology) and Professor of Surgery (Transplant); Director of Transplant Medicine; Director Outpatient Transplantation Service; Medical Director Adult and Pediatric Kidney Transplantation; and Medical Director Pancreas Transplantation at Yale School of Medicine

Christian P. Larsen, MD, Dphil

Professor of Surgery, Division of Transplantation, Department of Surgery and the former dean, Emory School of Medicine; founding Director of the Emory Transplant Center

Roslyn B. Mannon, MD

Professor of Medicine in the Division of Nephrology and Professor of Surgery in the Division of Transplantation; Director of Research for the Comprehensive Transplant Institute, University of Alabama at Birmingham Medicine

Peter Nickerson, MD, FRCPC

Clinical Nephrologist, Professor of Internal Medicine and Immunology, and Associate Dean for Research, University of Manitoba; Executive Medical Director, Organs and Tissue Office, at the Canadian Blood Services

Philip O'Connell, MD

Director of the Centre for Transplant and Renal Research and Director of Transplant Medicine and the Clinical Islet Transplant Program, Westmead Hospital

Emilio D. Poggio, MD, FASN

Professor of Medicine at the Cleveland Clinic Lerner College of Medicine of CWRU, and Medical Director, Kidney and Kidney Pancreas Transplant Program, at the Cleveland Clinic

Kathryn Wood, DPhil

Professor of Immunology Emerita in the Nuffield Department of Surgical Sciences at the University of Oxford

Weijia Zhang, PhD

Director, Integrative Bioinformatics and Associate Professor of Medicine, Mount Sinai Health Systems

Company Secretary

Salim Hamir, FCA

Chartered Accountant, Company Secretary and Head of Corporate Affairs EKF Diagnostics Holdings Plc


Media & Investor Relations

Tel: +44 (0)20 7933 8780

Walbrook PR Limited
4 Lombard Street

latest News


Positive results from FractalDx study published

Renalytix AI plc announces announces positive study results have been published in the Journal of Clinical Investigation (JCI) Insight... Read More →

Commercial scale manufacturing milestone for KidneyIntelX™ test materials

Renalytix AI plc announces announces that its in-vitro diagnostic manufacturing programme has reached a critical development milestone for the production materials used to measure blood-based.. Read More →

New York State Department of Health issues CLIA Certificate Number for Renalytix Lab

RenalytixAI announces announces that the New York State Department of Health has issued a Clinical Laboratory Improvement Amendment (CLIA) .. Read More →